14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $116.30 $116.30 Thursday, 4th Jan 2024 HZNP stock ended at $116.30. During the day the stock fluctuated 0% from a day low at $116.30 to a day high of $116.30.
90 days $116.30 $116.30
52 weeks $90.61 $116.38

Historical Horizon Therapeutics Public Limited Company prices

Date Open High Low Close Volume
May 31, 2023 $99.45 $100.76 $99.27 $100.03 2 655 764
May 30, 2023 $99.50 $99.78 $99.25 $99.35 870 191
May 26, 2023 $99.53 $100.13 $99.32 $99.61 1 813 328
May 25, 2023 $99.50 $100.23 $99.24 $99.88 1 148 789
May 24, 2023 $100.07 $100.20 $99.47 $99.50 1 742 871
May 23, 2023 $100.90 $101.14 $99.95 $100.10 2 027 936
May 22, 2023 $100.62 $100.81 $99.83 $100.57 1 761 157
May 19, 2023 $101.45 $102.00 $100.30 $100.75 2 286 802
May 18, 2023 $101.25 $101.95 $100.86 $101.63 2 857 887
May 17, 2023 $97.65 $101.93 $96.94 $100.51 10 759 532
May 16, 2023 $93.00 $97.00 $90.61 $96.34 20 946 700
May 15, 2023 $111.21 $112.38 $111.21 $112.25 1 747 704
May 12, 2023 $110.00 $111.38 $108.20 $111.00 5 461 834
May 11, 2023 $110.50 $110.60 $109.83 $110.03 1 519 667
May 10, 2023 $111.00 $111.08 $110.02 $110.40 1 936 770
May 09, 2023 $110.70 $111.38 $110.46 $110.87 1 664 289
May 08, 2023 $110.87 $111.15 $110.27 $110.84 2 885 294
May 05, 2023 $110.26 $112.76 $110.26 $112.38 2 707 268
May 04, 2023 $110.50 $110.70 $110.02 $110.29 1 830 389
May 03, 2023 $110.80 $111.50 $110.58 $110.80 1 375 704
May 02, 2023 $112.00 $112.05 $111.60 $111.76 767 933
May 01, 2023 $111.44 $112.00 $111.30 $111.95 922 037
Apr 28, 2023 $111.15 $112.14 $111.12 $111.16 2 001 522
Apr 27, 2023 $110.35 $111.19 $110.35 $111.03 907 884
Apr 26, 2023 $109.96 $110.72 $109.86 $110.53 1 102 836
Click to get the best stock tips daily for free!

About Horizon Therapeutics Public Limited Company

Horizon Therapeutics Public Limited Company Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-... HZNP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT